Clinical trial
Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials
NCT01832610
Study timeline
Study start (actual)2013-01-01Date precision: month
Registry last updated2019-07-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
HeartWare® VASDEVICE
Sponsors & collaborators
Medtronic Cardiac Rhythm and Heart Failurelead sponsor
Mapped research locations
ChicagoIllinois, United States2HoustonTexas, United States1BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1DurhamNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01832610 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.